Publications
- Rituximab based therapy followed by autologous stem cell transplantation leads to superior outcome and high rates of PCR negativity in patients with indolent B-cell lymphoproliferative disorders2009 | First Faculty of Medicine
- The use of Comparative Duplex PCR in Monitoring of Patients with Non-Hodgkin´s Lymphoma and Chronic Lymphocytic Leukaemia2005 | First Faculty of Medicine
- The use of Comparative Duplex PCR in Monitoring of Patients with Non-Hodgkin´s Lymphoma and Chronic Lymphocytic Leukaemia2005 | Faculty of Physical Education and Sport
- Chemotherapy alone may lead to a pcr negative stem cell harvest in transformed lymphoma refractory to rituximab2003 | First Faculty of Medicine
- Unusual Sequence of VDJ Rearrangement Revealed by Molecular Analysis in a Patient with Indolent Lymphoma2003 | First Faculty of Medicine
- Clinical Relevance of Semi-Quantitative Monitoring by Comparative PCR in Lymphomas2002 | First Faculty of Medicine
- Anti CD20 Antibody (Rituximab) Therapy Leads to High Molecular Remission Rate with Favourable Outcome in Patients with Non-Hodgkin's Lymphoma2001 | Faculty of Physical Education and Sport
- Detection and Significance of Chromosomal Abnormalities in Patients with non-Hodgkin s Lymphomas by Polymerase Chain Reaction.1999 | Faculty of Physical Education and Sport
- Molecular Monitoring of Non-Hodgkin s Lymphomas.1999 | Faculty of Physical Education and Sport
- Monitoring of Residual Disease in Non-Hodgkin s Lymphomas by Quantitative PCR (Preliminary Report).1999 | Faculty of Physical Education and Sport
Loading network view...